PASADENA, CA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback